The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
cephalon | 1250 |
ignyta | 117 |
cima labs | 51 |
cephalon france | 51 |
cancer research technology | 39 |
teva sante | 27 |
pharmacopeia | 11 |
anesta corporation | 6 |
millennium pharmaceuticals | 6 |
h. lundbeck | 6 |
cephalon | 57 |
ignyta | 19 |
cancer research technology | 5 |
teva sante | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
uracil derivatives as axl and c-met kinase inhibitors | 54 | 2011 |
fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor | 51 | 2012 |
generally linear effervescent oral fentanyl dosage form and methods of administering | 46 | 2003 |
proteasome inhibitors and methods of using the same | 38 | 2003 |
bendamustine pharmaceutical compositions for lyophilisation | 36 | 2005 |
pyridizinone derivatives | 36 | 2006 |
bendamustine derivatives and methods of using same | 35 | 2012 |
method for purifying a fused pyrrolocarbazole derivative | 30 | 2010 |
solid state forms of a quinazoline derivative and its use as a braf inhibitor | 30 | 2013 |
fused pyrrolocarbazoles | 30 | 2003 |